Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 4/20 | 0.36 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6417339 | 0.97 | LMNA (0.42) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL1931514 | 0.97 | LMNA (0.42) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL1932662 | 0.97 | LMNA (0.42) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL2848647 | 0.97 | LMNA (0.42) | OPRM1LMNADNM1TSHRTHRB | |
| Magnesium SCHEMBL10627767 | 0.97 | OPRM1 (0.40) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL9501255 | 0.97 | LMNA (0.42) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL1068793 | 0.97 | LMNA (0.42) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL1931396 | 0.97 | LMNA (0.42) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL10958705 | 0.97 | LMNA (0.42) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL1932427 | 0.97 | LMNA (0.42) | OPRM1LMNADNM1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 596 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4744105-A1 | ALKALI-SULFUR SECONDARY BATTERY AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2026-05-20 | — | — | EP | claimed |
| US-20250268255-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | ECOLAB USA INC. | 2025-08-28 | — | — | US | claimed |
| WO-2025011926-A1 | ALKALI-SULFUR SECONDARY BATTERY AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-01-16 | — | — | WO | claimed |
| CN-119111009-A | Electrolyte for lithium-sulfur battery and lithium-sulfur battery comprising same | 株式会社LG新能源 | 2024-12-10 | — | — | CN | claimed |
| CN-118813211-A | Energy-saving additive and application thereof in heat exchange system and heat exchange system | 上海维仕达环保科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| US-20240138407-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | ECOLAB USA INC. | 2024-05-02 | — | — | US | claimed |
| EP-3651588-B1 | METHOD FOR PREPARING A COLOUR-STABLE PREPARATION OF A MAGNESIUM CHLOROPHYLLIN ALKALI METAL SALT OR ALKALI EARTH METAL SALT FROM NATURAL SOURCES OF CHLOROPHYLL | GIVAUDAN SA (CH) | 2024-03-13 | — | — | EP | claimed |
| CN-115645298-B | Personal care composition, preparation method and application | 张家港格瑞特化学有限公司 | 2024-02-02 | — | — | CN | claimed |
| WO-2023224418-A1 | METHOD FOR PRODUCING FROM FATTY ALCOHOLS MONOMERS FOR PRODUCING VARIOUS SYNTHETIC RESINS | 안정오 | 2023-11-23 | — | — | WO | claimed |
| US-11807811-B2 | Flowback aid for fracturing fluids | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2023-11-07 | — | — | US | claimed |
| CN-1066432-C | Preparation of citraconic anhydride | RHONE POULENC CHIMIE (FR) | 2001-05-30 | — | — | CN | claimed |
| CN-1186453-A | Catalyst and process for producing amine | DOW CHEMICAL CO (US) | 1998-07-01 | — | — | CN | claimed |
| US-5670659-A | Preparation of citraconic anhydride | RHONE-POULENC CHIMIE (FR) | 1997-09-23 | — | — | US | claimed |
| EP-0665211-B1 | Process for preparing citraconic anhydride | RHONE POULENC CHIMIE (FR) | 1997-09-03 | — | — | EP | claimed |
| CN-1150584-A | Process for preparation of citraconic anhydride | RHONE POULENC CHIMIE (FR) | 1997-05-28 | — | — | CN | claimed |
| CN-1110676-A | Preparation of citraconic anhydride | RHONE POULENC CHIMIE (FR) | 1995-10-25 | — | — | CN | claimed |
| EP-0290283-B1 | METHOD FOR THE FROTH FLOTATION OF COAL | THE DOW CHEMICAL COMPANY (US) | 1993-05-26 | — | — | EP | claimed |
| CN-1013928-B | Coal froth flotation process | DOW CHEMICAL CO (US) | 1991-09-18 | — | — | CN | claimed |
| EP-0156512-B1 | PROCESS FOR PREPARING CATALYST COMPONENT FOR POLYMERIZATION OF OLEFINS | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1989-06-14 | — | — | EP | claimed |
| CN-88102559-A | The foam flotation method of coal | — | 1988-11-16 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250268255-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | CUTA, ARG1, LPO | OPRM1 3398/4885LMNA 2648/4885DNM1 2242/4885 |
| US-20240138407-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | CUTA, ARG1, LPO | OPRM1 3398/4885LMNA 2648/4885DNM1 2242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.